Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by a selective loss of dopaminergic neurons in the substantia nigra (SN). It has been suggested that microglial inflammation augments the progression of PD. Neuromelanin (NM), a complex polymer pigment found in catecholaminergic neurons, has sparked interest because of the suggestion that NM is involved in cell death in Parkinson's disease, possibly via microglia activation. To further investigate the possible role of NM in the pathogenesis of PD, we conducted in vivo experiments to find out whether microglial cells become activated after injection of human neuromelanin (NM) into (1) the cerebral cortex or (2) the substantia nigra to monitor in this PD-relevant model both microglial activation and possible neurodegeneration. In this study, adult male Wistar rats received an intracerebral injection of either NM, bacterial lipopolysaccharide (LPS, positive control), phosphate-buffered saline (PBS, negative control) or colloidal gold suspension (negative particular control). After different survival times (1, 8 or 12 weeks), brain slices from the cerebral cortex or substantia nigra (SN, 1 week) were stained with Iba-1 and/or GFAP antibody to monitor microglial and astrocytic reaction, and with tyrosine hydroxylase (TH) to monitor dopaminergic cell survival (SN group only). The injection of LPS induced a strong inflammatory response in the cortex as well in the substantia nigra. Similar results could be…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The archetype, riboflavin, acquires a dioxetane when illuminated, due to cycloaddition of 1O2* produced by excited riboflavin (115).”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [115]
In the citing paper
“FAD and FMN (flavin adenine dinucleotide and flavin mononucleotide) have electron transfer as their function (115), particularly in the mitochondria.”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [115]
In the citing paper
“In-vitro and in-vivo studies have confirmed the ability of neuromelanin to activate microglia and induce death of dopamine neurons.127,128”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [127]
In the citing paper
“In addition, the neuromelanin (dark, complex endogenous polymer derived from DA) can activate microglial cells, inducing neuroinflammation and neurodegeneration of dopaminergic neurons in PD (Zecca et al., 2008; Herrera et al., 2015).”
From The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma. (2017) · cites this paper as Zecca et al., 2008
In the citing paper
“Dopamine-derived quinones (DA-Q) can undergo intramolecular cyclization and oxidation to form leukochrome, aminochrome, and finally, neuromelanin, a pigment involved in neuroinflammation and neurodegeneration (Zecca et al. 2008).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Zecca et al. 2008
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045 · cited 5×
“Like other tissue macrophages in the Wrst line of host defence, microglia play a pivotal role as phagocytic, antigen-presenting cells acting in concert with invading immune cells to defend the immunological integrity of the CNS.”
InfluentialMicroglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557 · cited 1×
“, proteolytic enzymes, reactive oxygen intermediates (ROIs) or NO), and damage CNS cells [2, 4, 11, 21, 30].”
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287 · cited 1×
“... protective functions, by, for example, supplying glial-derived neurotrophic factor (GDNF), interferons and tumor necrosis factor (TNF-), they may participate in an ongoing cell death following the initial toxic insult by releasing various kinds of noxious factors such as cytokines (i.e., TNF-, IL-1, IL-6) or proin…”
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · cited 1×
“, proteolytic enzymes, reactive oxygen intermediates (ROIs) or NO), and damage CNS cells [2, 4, 11, 21, 30].”
Banati, R. B., Gehrmann, J., Schubert, P., & Kreutzberg, G. W. (1993) · Glia · doi:10.1002/glia.440070117 · Cited by 1,029
Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791 · cited 2×
“In parkinsonian brains, also the regions receiving projections from substantia nigra like putamen have areas with microglial activation, which is secondary to the degeneration of the neuronal processes [14].”
Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403495101 · Cited by 495
Self-citation
Cited by
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Self-citationOxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight
Bhat, A. H., Dar, K. B., Anees, S., Zargar, M. A., Masood, A., Sofi, M. A., & Ganie, S. A. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.07.025 · Cited by 928
Role of Oxidative Stress in Parkinson's Disease
Hwang, O. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.1.11 · Cited by 835
Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Trist, B. G., Hare, D. J., & Double, K. L. (2019) · Aging Cell · doi:10.1111/acel.13031 · Cited by 778
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
Self-citationNeuroinflammation in Parkinson's disease
Hirsch, E. C., Vyas, S., & Hunot, S. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70065-7 · Cited by 657
Basic mechanisms of neurodegeneration: a critical update
Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 596
Cognitive impairment following high fat diet consumption is associated with brain inflammation
Pistell, P. J., Morrison, C. D., Gupta, S., Knight, A. G., Keller, J. N., Ingram, D. K., & Bruce-Keller, A. J. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.11.010 · Cited by 596
Protective and toxic roles of dopamine in Parkinson's disease
Segura‐Aguilar, J., Paris, I., Muñoz, P., Ferrari, E., Zecca, L., & Zucca, F. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12686 · Cited by 498
Self-citationMelanins and melanogenesis: from pigment cells to human health and technological applications
d'Ischia, M., Wakamatsu, K., Cicoira, F., Di Mauro, E., Garcia‐Borron, J. C., Commo, S., Galván, I., Ghanem, G., Kenzo, K., Meredith, P., et al. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12393 · Cited by 490
Self-citationThe role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma.
Ramirez, A. I., de Hoz, R., Salobrar-Garcia, E., Salazar, J. J., Rojas, B., Ajoy, D., López-Cuenca, I., Rojas, P., Triviño, A., & Ramírez, J. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00214 · Cited by 466
“In addition, the neuromelanin (dark, complex endogenous polymer derived from DA) can activate microglial cells, inducing neuroinflammation and neurodegeneration of dopaminergic neurons in PD (Zecca et al., 2008; Herrera et al., 2015).”
BackgroundGlia: Initiators and progressors of pathology in Parkinson's disease
Halliday, G. M., & Stevens, C. H. (2011) · Movement Disorders · doi:10.1002/mds.23455 · Cited by 424
Implications of glial nitric oxide in neurodegenerative diseases
Yuste, J. E., Tarragon, E., Campuzano, C. M., & Ros-Bernal, F. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00322 · Cited by 356
The hallmarks of Parkinson's disease
Antony, P. M. A., Diederich, N. J., Krüger, R., & Balling, R. (2013) · The FEBS Journal · doi:10.1111/febs.12335 · Cited by 300
Recent advances in our understanding of neurodegeneration
Jellinger, K. A. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0240-y · Cited by 274
“2008), while human neuromelanin induces neuroinflammation and degeneration in the rat SN (Zecca et al. 2008) and aggregated aSyn activates microglia (Zhang et al.”
BackgroundIntegrating Pathways of Parkinson's Disease in a Molecular Interaction Map
Fujita, K. A., Ostaszewski, M., Matsuoka, Y., Ghosh, S., Glaab, E., Trefois, C., Crespo, I., Perumal, T. M., Jurkowski, W., Antony, P. M. A., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8489-4 · Cited by 273
Zhang, W., Phillips, K., Wielgus, A. R., Liu, J., Albertini, A., Zucca, F. A., Faust, R., Qian, S. Y., Miller, D. S., Chignell, C. F., et al. (2011) · Neurotoxicity Research · doi:10.1007/s12640-009-9140-z · Cited by 257
“We have also shown that human NM injected into rat SN induces microglia activation and degeneration of dopaminergic neurons but the mechanism involved is still unknown (Zecca et al. 2008).”
InfluentialSelf-citationThe neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases
Dusek, P., Roos, P. M., Litwin, T., Schneider, S. A., Flaten, T. P., & Aaseth, J. (2015) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.05.007 · Cited by 253
Aging Microglia—Phenotypes, Functions and Implications for Age-Related Neurodegenerative Diseases
Spittau, B. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00194 · Cited by 253
Neurodegenerative Diseases – Is Metabolic Deficiency the Root Cause?
Muddapu, V. R., Dharshini, S. A. P., Chakravarthy, V. S., & Gromiha, M. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00213 · Cited by 251
White, C. L., Pistell, P. J., Purpera, M. N., Gupta, S., Fernandez-Kim, S.-O., Hise, T. L., Keller, J. N., Ingram, D. K., Morrison, C. D., & Bruce-Keller, A. J. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.04.002 · Cited by 245
“Microglial reactivity was evaluated by measuring expression of Iba-1, which is a 17-kDa calcium binding protein that is specifically expressed in macrophages/ microglia and is upregulated during the in vivo activation of these cells (Hilton et al., 2008), (Lee et al., 2008), (Zecca et al., 2008).”
Neuromelanin of the Human Substantia Nigra: An Update
Zucca, F. A., Basso, E., Cupaioli, F. A., Ferrari, E., Sulzer, D., Casella, L., & Zecca, L. (2014) · Neurotoxicity Research · doi:10.1007/s12640-013-9435-y · Cited by 243
Self-citationUrrutia, P. J., Mena, N. P., & Núñez, M. T. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00038 · Cited by 243
Singh, S. S., Rai, S. N., Birla, H., Zahra, W., Rathore, A. S., & Singh, S. P. (2020) · Neurotoxicity Research · doi:10.1007/s12640-019-00147-2 · Cited by 215
Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases
Bencherif, M., Lippiello, P. M., Lucas, R., & Marrero, M. B. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0525-1 · Cited by 202
Inflammation in Parkinson's Disease
Tufekci, K. U., Meuwissen, R., Genc, S., & Genc, K. (2012) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/b978-0-12-398314-5.00004-0 · Cited by 196
Lipopolysaccharide Animal Models for Parkinson's Disease
Liu, M., & Bing, G. (2011) · Parkinson's Disease · doi:10.4061/2011/327089 · Cited by 190
Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease
Hirsch, E. C., & Standaert, D. G. (2021) · Movement Disorders · doi:10.1002/mds.28075 · Cited by 189
Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair
Vivekanantham, S., Shah, S., Dewji, R., Dewji, A., Khatri, C., & Ologunde, R. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2014.982795 · Cited by 171
“established that the intracerebral injection of neuromelanin induced an ‘acute and strong inflammatory microglial activation’ when compared to gold which was used as a particular control [29].”
BackgroundIron dysregulation in movement disorders
Dusek, P., Jankovic, J., & Le, W. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.054 · Cited by 169
Lipid-Mediated Oxidative Stress and Inflammation in the Pathogenesis of Parkinson's Disease
Farooqui, T., & Farooqui, A. A. (2011) · Parkinson's Disease · doi:10.4061/2011/247467 · Cited by 156
Natural Melanin: Current Trends, and Future Approaches, with Especial Reference to Microbial Source
El‐Naggar, N. E., & Saber, W. I. A. (2022) · Polymers · doi:10.3390/polym14071339 · Cited by 148
Iron, Neuroinflammation and Neurodegeneration
Ward, R. J., Dexter, D. T., & Crichton, R. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137267 · Cited by 148
Engineered nanoparticles, How brain friendly is this new guest?
Cupaioli, F. A., Zucca, F. A., Boraschi, D., & Zecca, L. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.05.002 · Cited by 139
Self-citationUrrutia, P. J., Bórquez, D. A., & Núñez, M. T. (2021) · Antioxidants · doi:10.3390/antiox10010061 · Cited by 138
The Locus Coeruleus in Aging and Alzheimer’s Disease: A Postmortem and Brain Imaging Review
Beardmore, R., Hou, R. H., Darekar, A., Holmes, C., & Boche, D. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210191 · Cited by 135
The Link between Gut Dysbiosis and Neuroinflammation in Parkinson’s Disease
Baizabal-Carvallo, J. F., & Alonso-Juarez, M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.030 · Cited by 130
α-Synuclein in Parkinson’s disease: causal or bystander?
Riederer, P. F., Berg, D., Casadei, N., Cheng, F., Claßen, J., Dresel, C., Jost, W. H., Krüger, R., Müller, T., Reichmann, H., et al. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02025-9 · Cited by 130
Members, E. W. E., Terron, A., Bal-Price, A., Paini, A., Monnet-Tschudi, F., Bennekou, S. H., Leist, M., & Schildknecht, S. (2018) · Archives of Toxicology · doi:10.1007/s00204-017-2133-4 · Cited by 124
“Intracerebral injection of neuromelanin, a derivative of l-DOPA that accumulates in catecholaminergic neurons, causes an inflammatory activation of glial cells in the rat brain, indicating that degenerating DA neurons are leading to neuroinflammation (Zecca et al. 2008).”
BackgroundDepboylu, C., Stricker, S., Ghobril, J.-P., Oertel, W. H., Priller, J., & Höglinger, G. U. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.08.020 · Cited by 112
Nicotinic Attenuation of Central Nervous System Inflammation and Autoimmunity
Shi, F., Piao, W.-H., Kuo, Y., Campagnolo, D. I., Vollmer, T. L., & Lukas, R. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1730 · Cited by 109
Expression of HMGB1 and RAGE in rat and human brains after traumatic brain injury
Gao, T.-L., Yuan, X.-T., Yang, D., Dai, H.-L., Wang, W.-J., Peng, X., Shao, H.-J., Jin, Z.-F., & Fu, Z.-J. (2012) · Journal of Trauma and Acute Care Surgery · doi:10.1097/ta.0b013e31823c54a6 · Cited by 102
Wise, R. M., Wagener, A., Fietzek, U. M., Klopstock, T., Mosharov, E. V., Zucca, F. A., Sulzer, D., Zecca, L., & Burbulla, L. F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105920 · Cited by 100
Self-citationMaatouk, L., Compagnion, A.-C., Sauvage, M.-A. C.-D., Bemelmans, A.-P., Leclere-Turbant, S., Cirotteau, V., Tohme, M., Beke, A., Trichet, M., Bazin, V., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04569-y · Cited by 95
NOX2 deficiency attenuates markers of adiposopathy and brain injury induced by high-fat diet
Pepping, J. K., Freeman, L. R., Gupta, S., Keller, J. N., & Bruce-Keller, A. J. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00398.2012 · Cited by 94
Anti-melanin antibodies are increased in sera in Parkinson's disease
Double, K. L., Rowe, D. B., Carew‐Jones, F., Hayes, M., Chan, D. K. Y., Blackie, J., Corbett, A. J., Joffe, R., Fung, V. S. C., Morris, J. G., et al. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.002 · Cited by 93
ATP7A-Regulated Enzyme Metalation and Trafficking in the Menkes Disease Puzzle
Horn, N., & Wittung-Stafshede, P. E. (2021) · Biomedicines · doi:10.3390/biomedicines9040391 · Cited by 90
Depboylu, C., Schäfer, M. K.-H., Arias-Carrión, O., Oertel, W. H., Weihe, E., & Höglinger, G. U. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31820805b9 · Cited by 89
The role of T cells in the pathogenesis of Parkinson’s disease
Chen, Z., Chen, S., & Liu, J. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.08.002 · Cited by 86
Wilms, H., Rosenstiel, P., Romero-Ramos, M., Arlt, A., Schäfer, H., Seegert, D., Kahle, P. J., Odoy, S., Claasen, J. H., Holzknecht, C., et al. (2009) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200902200405 · Cited by 82
Self-citationMelanin and neuromelanin binding of drugs and chemicals: toxicological implications
Karlsson, O., & Lindquist, N. G. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1757-0 · Cited by 81
Olmedo‐Díaz, S., Estévez-Silva, H. M., Orädd, G., af Bjerkén, S., Marcellino, D. J., & Virel, A. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.08.023 · Cited by 79
Naoi, M., Maruyama, W., Yi, H., Inaba, K., Akao, Y., & Shamoto‐Nagai, M. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0309-7 · Cited by 75
l‐DOPA‐induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?
Carta, A. R., Mulas, G., Bortolanza, M., Duarte, T., Pillai, E., Fisone, G., Vozari, R. R., & Del‐Bel, E. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13482 · Cited by 75
Riederer, P. F., Nagatsu, T., Youdim, M. B. H., Wulf, M., Dijkstra, J. M., & Sian‐Hülsmann, J. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02630-9 · Cited by 75
The Neuromelanin Paradox and Its Dual Role in Oxidative Stress and Neurodegeneration
Moreno-García, A., Kun, A., Calero, M., & Calero, O. (2021) · Antioxidants · doi:10.3390/antiox10010124 · Cited by 74
Zhang, S., Shao, S.-Y., Song, X., Xia, C., Yang, Y., Zhang, P., & Chen, N. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2015.09.009 · Cited by 72
Iron accumulation in Parkinson’s disease
Mochizuki, H., & Yasuda, T. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0905-9 · Cited by 70
Genetically engineered mouse models of Parkinson's disease
Crabtree, D. M., & Zhang, J. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.07.019 · Cited by 70
Zucca, F. A., Capucciati, A., Bellei, C., Sarna, M., Sarna, T., Monzani, E., Casella, L., & Zecca, L. (2023) · IUBMB Life · doi:10.1002/iub.2654 · Cited by 69
“These neuroinflammatory/neurodegenerative effects have been also investigated by using in vivo models: injection of human NM into rat SN caused strong microglia activation with significant degeneration of dopaminergic neurons.(52,53) In the intranigral injection FIGURE 1 Initial steps of the biosynthetic pathway to th…”
BackgroundSelf-citationChelating principles in Menkes and Wilson diseases
Horn, N., Møller, L. B., Nurchi, V. M., & Aaseth, J. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.10.009 · Cited by 68
Biesemeier, A., Eibl, O., Eswara, S., Audinot, J., Wirtz, T., Pezzoli, G., Zucca, F. A., Zecca, L., & Schraermeyer, U. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13648 · Cited by 67
Self-citationNOX activity in brain aging: Exacerbation by high fat diet
Bruce-Keller, A. J., White, C. L., Gupta, S., Knight, A. G., Pistell, P. J., Ingram, D. K., Morrison, C. D., & Keller, J. N. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.03.006 · Cited by 67
Nagatsu, T., Nakashima, A., Watanabe, H., Ito, S., Wakamatsu, K., Zucca, F. A., Zecca, L., Youdim, M. B. H., Wulf, M., Riederer, P. F., et al. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02617-6 · Cited by 65
Self-citationThe Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
Jurcău, A., Andronie-Cioară, F. L., Nistor-Cseppento, C. D., Pașcalău, N., Rus, M., Vasca, E., & Jurcău, M. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914582 · Cited by 63
Neuromelanin activates proinflammatory microglia through a caspase-8-dependent mechanism
Viceconte, N., Burguillos, M. A., Herrera, A. J., De Pablos, R. M., Joseph, B., & Venero, J. L. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0228-x · Cited by 61
Badawi, G. A., Fattah, M. A. A. E., Zaki, H. F., & Sayed, M. I. E. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-9998-3 · Cited by 57
Melanin affinity and its possible role in neurodegeneration
Karlsson, O., & Lindquist, N. G. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1062-5 · Cited by 55
Muddapu, V. R., & Chakravarthy, V. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-81185-9 · Cited by 55
Human neuromelanin an endogenous microglial activator for dopaminergic neuron death
Zhang, W. (2013) · Frontiers in Bioscience · doi:10.2741/e591 · Cited by 53
Self-citationMuñoz, P., Paris, I. B., Sanders, L. H., Greenamyre, J. T., & Segura‐Aguilar, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.03.010 · Cited by 53
Mitochondria-mediated damage to dopaminergic neurons in Parkinson's disease (Review)
Liu, X., Wang, Y., Yu, X., Li, D., & Li, G. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3255 · Cited by 53
In vivo detection of lateral–ventral tier nigral degeneration in Parkinson's disease
Huddleston, D. E., Langley, J. A., Sedlacik, J., Boelmans, K., Factor, S. A., & Hu, X. P. (2017) · Human Brain Mapping · doi:10.1002/hbm.23547 · Cited by 51
Yang, K., Zeng, L., Zeng, J., Deng, Y., Wang, S., Xu, H., He, Q., Yuan, M., Luo, Y., Ge, A., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102063 · Cited by 50
Ferrari, E., Capucciati, A., Prada, I., Zucca, F. A., D’Arrigo, G., Pontiroli, D., Bridelli, M. G., Sturini, M., Bubacco, L., Monzani, E., et al. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00231 · Cited by 49
Self-citationMuddapu, V. R., Mandali, A., Chakravarthy, S. V., & Ramaswamy, S. (2019) · Frontiers in Neural Circuits · doi:10.3389/fncir.2019.00011 · Cited by 49
Watanabe, H., Dijkstra, J. M., & Nagatsu, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042009 · Cited by 48
Neuromelanin is an immune stimulator for dendritic cells in vitro
Oberländer, U., Pletinckx, K., Döhler, A., Müller, N., Lutz, M. B., Arzberger, T., Riederer, P., Gerlach, M., Koutsilieri, E., & Scheller, C. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-116 · Cited by 48
Inhibitory effect of ginsenoside Rg1 on lipopolysaccharide-induced microglial activation in mice
Hu, J., Song, X., Chu, S., Chen, J., Ji, H., Chen, X., Yuan, Y., Han, N., Zhang, J., & Chen, N. (2010) · Brain Research · doi:10.1016/j.brainres.2010.11.069 · Cited by 48
Lipotoxicity, neuroinflammation, glial cells and oestrogenic compounds
Hidalgo‐Lanussa, O., Báez-Jurado, E., Echeverría, V., Ashraf, G. M., Sahebkar, A., García‐Segura, L. M., Melcangi, R. C., & Barreto, G. E. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12776 · Cited by 48
Jayaraj, R. L., Beiram, R., Azimullah, S., Meeran, M. F. N., Ojha, S. K., Adem, A., & Jalal, F. Y. (2019) · Molecules · doi:10.3390/molecules24112182 · Cited by 48
Age and Parkinson’s Disease-Related Neuronal Death in the Substantia Nigra Pars Compacta
Eriksen, N., Stark, A. K., & Pakkenberg, B. (2009) · Springer eBooks · doi:10.1007/978-3-211-92660-4_16 · Cited by 44
Leathem, A., Ortíz, T., Dennis, J. M., & Witting, P. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136923 · Cited by 43
Relevance of chronic stress and the two faces of microglia in Parkinson's disease
Herrera, A. J., Espinosa-Oliva, A. M., Carrillo-Jiménez, A., Oliva-Martín, M. J., García-Revilla, J., García-Quintanilla, A., de Pablos, R. M., & Venero, J. L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00312 · Cited by 42
“Several studies have shown that NM is able to induce microglial activation, initiating neuroinflammation and neurodegeneration of dopaminergic neurons (Wilms et al., 2003; Zecca et al., 2008; Karlsson and Lindquist, 2013; Nie et al., 2013).”
BackgroundXing, B., Xin, T., Zhao, L., Hunter, R. L., Chen, Y., & Bing, G. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.04.010 · Cited by 42
Cuzzubbo, S., & Carpentier, A. F. (2021) · Cancers · doi:10.3390/cancers13061463 · Cited by 42
Brain injury caused by HIV protease inhibitors: Role of lipodystrophy and insulin resistance
Gupta, S., Knight, A. G., Losso, B. Y., Ingram, D. K., Keller, J. N., & Bruce‐Keller, A. J. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2012.04.010 · Cited by 41
Inflammatory Animal Models of Parkinson’s Disease
García‐Revilla, J., Herrera, A. J., de Pablos, R. M., & Venero, J. L. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-213138 · Cited by 40
Ferrari, E., Engelen, M., Monzani, E., Sturini, M., Girotto, S., Bubacco, L., Zecca, L., & Casella, L. (2012) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-012-0951-7 · Cited by 38
Self-citationCrichton, R. R., Ward, R. J., & Hider, R. C. (2019) · Pharmaceuticals · doi:10.3390/ph12030138 · Cited by 38
Iannitelli, A. F., & Weinshenker, D. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105287 · Cited by 37
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Pirooznia, S. K., Rosenthal, L. S., Dawson, V. L., & Dawson, T. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000189 · Cited by 37
Capucciati, A., Zucca, F. A., Monzani, E., Zecca, L., Casella, L., & Hofer, T. (2021) · Antioxidants · doi:10.3390/antiox10060824 · Cited by 36
“In vitro experiments have shown that in neuron/microglia co-cultures, microglia activated by NM induced neuronal death by releasing pro-inflammatory molecules and reactive species and this effect was further reproduced in vivo, upon injection of NM into rat SN [11,37].”
BackgroundSelf-citationLecours, C., St-Pierre, M.-K., Picard, K., Bordeleau, M., Bourque, M., Awogbindin, I. O., Benadjal, A., Ibanez, F. G., Gagnon, D., Cantin, L., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.07.044 · Cited by 36
Li, D., Guang-ren, L., Zhang, B., FENG, J.-J., & Zhao, H. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2430 · Cited by 36
Hwang, K., Langley, J. A., Tripathi, R., Hu, X. P., & Huddleston, D. E. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282684 · Cited by 33
Melanin biopolymers from microbial world with future perspectives—a review
Michael, H. S. R., Subiramanian, S. R., Thyagarajan, D., Bobby, M. N., Saravanakumar, V. K., Govindaraj, M., Maheswari, K. M., Karthikeyan, N., & Kumar, C. R. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03642-5 · Cited by 33
Metadata
- Authors
- Zecca, L., Wilms, H., Geick, S., Claasen, J.-H., Brandenburg, L.-O., Holzknecht, C., Panizza, M. L., Zucca, F. A., Deuschl, G., Sievers, J., & Lucius, R.
- Affiliations
- Institute of Biomedical Technologies (IT)
- Heidelberg University (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- Corresponding author
- Lucius, Ralph
- Venue
- Acta Neuropathologica
- Published
- 2008-03-15
- Volume
- 116
- Issue
- 1
- Pages
- 47-55
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W1979975559
- Cited by
- 205
- References
- 37
- Citations by year
- 2026: 4 · 2025: 16 · 2024: 9 · 2023: 17 · 2022: 14 · 2021: 17 · 2020: 10 · 2019: 12 · 2018: 4 · 2017: 8 · 2016: 9 · 2015: 13 · 2014: 11 · 2013: 12 · 2012: 15
- FWCI
- 7.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- neuromelanin, Parkinson's disease, substantia nigra, microglial activation, neuroinflammation, neurodegeneration, dopaminergic neuron loss, catecholaminergic neurons, astrocyte activation, lipopolysaccharide, intracerebral injection, Iba1, tyrosine hydroxylase
- MeSH terms
- Animals, Humans, Immunohistochemistry, Inflammation, Male, Melanins, Nerve Degeneration, Neurons, Substantia Nigra, Tyrosine 3-Monooxygenase, Cell Death, Rats, Wistar, Microglia, Parkinsonian Disorders, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.